About

With its core activity in Reproductive Genetics, in 2014 Bioarray pioneered the use of NGS technology for PGS, launching this service worldwide after comprehensive validation through comparison of nearly 100 embryos with NGS and CGH, the other well-established 24-chromosomes PGS technique, where full correspondence was obtained.

Using NGS for PGS provides a more affordable cost thanks to the NGS high throughput. Moreover those couples resorting to IVF to prevent a single-gene disorder being passed on to their children (e.g. cystic fibrosis), can now undergo such a focused genetic study (PGD) together with the PGS in a combined procedure.

Bioarray reproductive portfolio also includes prenatal diagnosis, recurrent miscarriage testing and preconception NGS panel. Bioarray lab, based in Alicante-Spain, is also a leading provider of research services on genotyping and gene expression studies for medicine, biology and pharma research groups.

Our great proficiency in bioinformatics, an essential aspect of genetic analysis, allows us to deliver meaningful result reports for physicians, geneticists and researchers, and with short turnaround times.